• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

Custom Skincare Packaging Artwork Ownership: What Should a U.S. OEM Contract Specify?

Most U.S. body care brands spend weeks negotiating price per unit and almost no time negotiating who owns the dieline, the layered artwork file, the color standard, or the approved label version that actually…

Category: Body Care Sourcing Guides • Author: laeyo • Published: 2026-11-17 • Views: 4

Most U.S. body care brands spend weeks negotiating price per unit and almost no time negotiating who owns the dieline, the layered artwork file, the color standard, or the approved label version that actually went to print. That gap becomes expensive the moment you switch suppliers, add a second contract manufacturer, launch a line extension, or need to prove to a retailer that the label on shelf matches the approved regulatory version. This guide sets out what a U.S. OEM contract should specify about custom skincare packaging artwork ownership — in procurement language you can forward to a supplier or hand to counsel. Informational only, not legal advice.

Why Artwork Ownership Is a Production Issue, Not a Design Issue

Artwork is the interface where formulation, claims, and U.S. labeling law meet. It is also the file set that a packaging supplier, printer, and filler all act on. When ownership and version control are undefined, three predictable failures follow:

  • Supplier lock-in. Your brand cannot move to a second filler or printer because nobody holds usable native files, only flattened PDFs.
  • Silent version drift. A copy change is approved for one market or one fill size and never propagated, so an obsolete label reaches a print run.
  • Unsupported label claims. The label in market does not match the formulation version the safety and technical file was built on.

The practical rule: treat artwork as a controlled deliverable with an owner, an ID, an approval state, and a handover condition — the same way you treat a specification or a batch record.

What “Artwork” Should Be Defined to Include

Contracts fail when “artwork” is left undefined and both sides assume something narrower. Define it as an asset inventory, not a phrase.

  • Dieline and structure files for bottle labels, tubes, jars, cartons, shrink sleeves, and pouches — including the version tied to a specific container supplier.
  • Native layered source files (plus export-ready PDF/X files) for front panel, back panel, warnings, and INCI block.
  • Copy blocks as separate versioned elements: front copy, back copy, warnings, INCI/ingredient list — each confirmed independently.
  • Color standards — master color targets, print references, and decoration specs for silkscreen, hot stamp, spray, or label substrate.
  • Barcodes and QR codes with verified scan performance on the final substrate, not on screen.
  • Photography, illustrations, icon sets, and pattern assets created or commissioned for the project.
  • Regulatory technical inputs supplied by the manufacturer: ingredient/INCI data, allergen declarations, warning statements, net content basis, and batch code placement conventions.
  • The Golden Packaging Sample record — the physical approved reference plus its linked artwork version number.

Clauses a U.S. OEM Contract Should Specify

1. Assignment vs. license — decide both, not one

  • Assignment: newly created artwork, dielines, and decoration specs commissioned and paid for by the brand transfer to the brand.
  • License back: the manufacturer retains a limited, non-exclusive license to use the artwork solely to manufacture, fill, and document the brand’s orders — nothing more.
  • Trigger point: state whether transfer occurs on creation, on approval, or on full payment, and what happens on termination.
  • Moral rights waiver where applicable, so the brand can modify artwork without a further consent step.

2. Third-party assets and fonts

  • Name who warrants that fonts, stock imagery, and icon libraries are licensed for commercial print and digital use.
  • Require the license scope to cover the brand, its retailers, and its printers — not just the OEM’s internal use.
  • Require delivery of licensed font files or an approved outlined alternative, so a future printer is not blocked.

3. Version control and obsolete control

  • Every market, fill size, and variant gets a unique Artwork ID.
  • Copy version, regulatory approval status, brand approval status, and packaging proof status are tracked as separate states.
  • Superseded files are formally marked obsolete and removed from the print-ready folder — not merely renamed.
  • The contract should state who is authorized to release artwork to print, and that print release requires documented regulatory approval.

4. Approval gates and sign-off authority

  • Define the sequence: brand visual approval → regulatory approval → packaging proof → golden sample → production release.
  • Name the individual roles (not just “the brand”) authorized to approve each gate.
  • State that a change request after print release triggers a documented change order with cost and schedule impact.

5. Golden Packaging Sample custody

The approved physical sample is the only valid production comparator. A PDF is not a golden sample. Specify that the contract requires a physical master that captures container material, master color, cap/pump color, all decoration effects, liquid appearance, artwork version number, scanned barcode, batch code position, and durability after transport and bathroom-environment exposure — plus who holds the retained copy and for how long.

6. U.S. regulatory responsibility split

  • Manufacturer supplies: formulation and ingredient data, COA/SDS, batch and quality system records, facility information, safety support documentation, and label technical inputs.
  • Brand/importer owns: the U.S. Responsible Person designation, product listing, import and sale compliance, state-level requirements, and final label and advertising claim compliance.
  • Red line to write in: facility registration and product listing must never be described as FDA approval, certification, or endorsement in artwork, sales sheets, or marketing.
  • Label mechanics: the principal display panel must carry product identity and net quantity clearly; required warnings must be prominent; if foreign-language copy appears, required information must comply with the corresponding language rules.

7. Records, retention, and audit access

  • State who retains approved label versions, proofs, and print-release records, and for how long.
  • Confirm the brand can obtain copies on request within a defined window — critical during a retailer audit or a supplier transition.

8. Termination handover

  • List exactly what is delivered within a set number of days: native files, dielines, color standards, fonts, barcode assets, approved proof set, and the version registry.
  • State the format and that delivery is not conditioned on unrelated commercial disputes.
  • Include a confidentiality clause preventing reuse of brand artwork, imagery, or packaging design for any other client.

Deliverable Handover Table

Asset Typically created by What the contract should state Evidence to request
Dieline / structure file Packaging supplier or OEM Assigned to brand; usable with any qualified printer Native dieline file with dimensions and substrate spec
Layered label artwork OEM design or brand agency Full assignment on payment; license back to OEM for production Native source file plus PDF/X print file
Copy blocks (front/back/warnings/INCI) Brand with OEM technical input Versioned separately under one Artwork ID Copy version log with approval dates
Color and decoration standard OEM with decorator Master color retained; tolerance defined Signed master color target and proof
Barcode / QR artwork Brand Verified on final substrate at final print size Scan verification record
Photography and illustrations Agency or OEM License scope covers brand, retailers, and printers License terms or assignment confirmation
Golden Packaging Sample OEM Custody, retention period, and comparator status defined Signed golden sample with artwork version ID
Regulatory label technical inputs OEM Provided per formula version; updates on reformulation INCI, allergen, and warning statement sheet

What to Request From Your OEM Before Signing

  • Request: the artwork asset inventory for your SKU. Evidence: written list of every file type in the handover pack. Acceptance: native files named, not just “print-ready PDF.”
  • Request: the version control method. Evidence: a sample Artwork ID log showing copy version, regulatory approval, brand approval, and proof status. Acceptance: obsolete files marked and segregated.
  • Request: the print-release authorization flow. Evidence: written approval gate sequence with named approver roles. Acceptance: no print release without documented regulatory approval.
  • Request: the golden sample definition. Evidence: checklist covering material, master color, decoration, barcode scan test, batch code position, and durability testing. Acceptance: physical master retained and referenced to an artwork version.
  • Request: the package–product compatibility validation plan. Evidence: compatibility, leakage, pump/dispense function, drop/transport, filling-line match, and label adhesion results. Acceptance: validation completed on the specific formula–container–closure combination, not on a similar product.
  • Request: the regulatory responsibility matrix. Evidence: a written split of manufacturer-supplied documents versus brand/importer obligations. Acceptance: Responsible Person and U.S. agent roles named in writing.
  • Request: the termination handover clause. Evidence: draft clause with deliverable list and timeline. Acceptance: handover not conditioned on unrelated disputes.
  • Request: the confidentiality and non-reuse clause. Evidence: contract language covering artwork, imagery, and packaging design. Acceptance: no portfolio or case-study use without written consent.

Failure Modes to Design Out of the Contract

  • Flattened files only. Symptom: a new printer cannot adjust the label. Root cause: native files never handed over. Prevention: name file formats in the deliverable schedule.
  • Obsolete artwork printed. Symptom: an old claim or old net quantity appears on shelf. Root cause: no obsolete control. Prevention: require an Artwork ID registry and print-release authorization.
  • One-market copy update. Symptom: two markets show different warnings. Root cause: shared files without separated copy versions. Prevention: separate front, back, warnings, and INCI version states.
  • Label adhesion or decoration failure. Symptom: edge lift, scuffing, or color shift after transit. Root cause: artwork approved on a proof, not on the production substrate. Prevention: approve on the golden sample after durability exposure.
  • Pump or closure mismatch. Symptom: dispense failure or leakage with a higher-viscosity or oil-based body care formula. Root cause: components validated as individual parts, not as a system. Prevention: validate the full product–package system with the actual formula.
  • Unsupported claim on pack. Symptom: retailer challenge or regulatory query. Root cause: claims added at artwork stage without technical review. Prevention: require manufacturer technical review of concentration, ingredient, and efficacy wording before print release.
  • Registration described as approval. Symptom: marketing copy implies FDA endorsement. Root cause: misread regulatory status. Prevention: contract language prohibiting that framing across artwork and sales materials.

FAQ

Who owns the dieline if the packaging supplier drew it?

Ownership depends entirely on what the contract says, not on who drew it. If the brand commissioned and paid for the structure for its exclusive use, the contract should assign the dieline and any associated tooling rights to the brand, with the supplier retaining only a production license. If the dieline is a supplier’s standard stock structure, expect a limited license rather than an assignment — clarify this before you approve the design.

Do we really need the native layered files, or is a print-ready PDF enough?

A print-ready PDF is enough to print once. It is not enough to change a net quantity, add a warning, reprint with a different printer, or prove what was approved. Specify native source files plus export files, and specify them as a handover deliverable rather than a favor.

Can the OEM show our packaging in its portfolio or on its website?

Not unless you agree to it. Default to a written clause requiring prior written consent for any portfolio, case study, trade show, or social use of your artwork, packaging design, or product imagery, with a defined revocation right.

Who is responsible if a label is printed with outdated regulatory information?

That is determined by the approval and print-release workflow you contract for. The clean structure is: the manufacturer supplies current technical label inputs tied to the formula version; the brand approves the final label and claims; the manufacturer releases to print only against documented approval. Write the sequence down, name the approver roles, and require change orders for post-release edits.

How long should the OEM keep approved artwork and proofs?

Set the retention period in the contract rather than relying on default practice, and pair it with an on-request copy obligation within a defined number of business days. This matters most during retailer audits, reformulations, and supplier transitions.

Ready to structure an artwork ownership and handover schedule for your next body care program? Share your target market, SKUs and formats, positioning, packaging direction, and timeline target, and the team can respond with a scoped proposal and sample plan. Request a Quote

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).